With positive early data, Biontech looking to supply chain requirements for COVID-19 vaccine Nov. 10, 2020 By Nuala Moran No Comments LONDON – Biontech SE is looking ahead from the announcement on Nov. 9 of 90% efficacy in the interim analysis of the phase III trial of its COVID-19 vaccine to outline shipping and distribution plans.Read More